Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University; German Red Cross Blood Service Baden-Württemberg- Hessen, Mannheim, Germany.
AIDS Res Ther. 2013 Nov 18;10(1):26. doi: 10.1186/1742-6405-10-26.
CCR5-delta32 heterozygous individuals are susceptible to HIV-1. However, it is not clear if there is a relevant protective effect against transmission and a beneficial effect in terms of HIV progression which cannot be attributed to CCR5 surface density alone. Therefore we investigated HIV-1 dependency factors (HDF) which might be differently regulated in CCR5 wild type (WT) and CCR5-delta32 heterozygous individuals.
We examined CD34+ hematopoietic progenitor cells derived from bone marrow samples from 19 healthy volunteers, 12 individuals with CCR5 WT and 7 with heterozygous CCR5-delta32 deletion. Samples were analyzed using a global gene expression oligonucleotide microarray (HG-U133plus 2.0, Affymetrix Inc.).
A total of 205 genes were found with altered expression (3fold difference, present call rate of 75%, p < 0.05) and 7 of these had a connection to HIV-1 pathogenesis. In 4 genes: TOP1, CXCR2, SREBF2, and TAP we found a different regulation which was consistent with a supposed beneficial effect for CCR5-delta32 heterozygotes.
The CCR5-delta32 deletion is associated with other HDFs in HIV-1 pathogenesis as a possible explanation for beneficial effects regarding the deletion leading to a variant expression profile in heterozygous carriers of this mutation.
CCR5-delta32 杂合子个体易感染 HIV-1。然而,目前尚不清楚是否存在针对传播的相关保护作用,以及是否存在 HIV 进展方面的有益作用,而这种作用不能仅归因于 CCR5 表面密度。因此,我们研究了 HIV-1 依赖因子(HDF),这些因子在 CCR5 野生型(WT)和 CCR5-delta32 杂合子个体中可能受到不同的调节。
我们检测了来自 19 名健康志愿者、12 名 CCR5 WT 个体和 7 名 CCR5-delta32 杂合子缺失个体的骨髓样本中 CD34+造血祖细胞。使用全基因表达寡核苷酸微阵列(HG-U133plus 2.0,Affymetrix Inc.)分析样本。
共发现 205 个基因表达发生改变(差异 3 倍,存在率为 75%,p<0.05),其中 7 个与 HIV-1 发病机制有关。在 4 个基因:TOP1、CXCR2、SREBF2 和 TAP 中,我们发现了一种不同的调节方式,这与 CCR5-delta32 杂合子的预期有益作用一致。
CCR5-delta32 缺失与 HIV-1 发病机制中的其他 HDF 相关,这可能是解释这种突变的杂合子携带者中缺失导致变异表达谱的有益作用的一种可能机制。